ResMed Inc. (ASX: RMD)
Australia
· Delayed Price · Currency is AUD | Market Cap | 47.64B |
| Revenue (ttm) | 6.63B |
| Net Income (ttm) | 1.43B |
| Shares Out | 1.47B |
| EPS (ttm) | 0.96 |
| PE Ratio | 33.43 |
| Forward PE | 23.87 |
| Dividend | 0.29 (0.89%) |
| Ex-Dividend Date | May 8, 2024 |
| Volume | 991,182 |
| Open | 32.61 |
| Previous Close | 32.78 |
| Day's Range | 32.39 - 32.65 |
| 52-Week Range | 21.14 - 34.27 |
| Beta | 0.64 |
| Analysts | n/a |
| Price Target | 35.13 (+8.33%) |
| Earnings Date | Aug 1, 2024 |
About ResMed
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. It operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics... [Read more]
Financial Performance
In 2023, ResMed's revenue was $4.22 billion, an increase of 32.10% compared to the previous year's $3.20 billion. Earnings were $897.56 million, an increase of 89.16%.
Financial numbers in USD Financial StatementsNews
ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy
SAN DIEGO, May 16, 2024 (GLOBE NEWSWIRE) -- When: May 17–22, 2024 Where: San Diego Convention Center (SDCC) | 111 Harbor Dr. San Diego, CA 92101 Marriott Marquis...
3 Hot Stocks to Buy That Still Look Undervalued
#Morningstar #HotStocks #StockInvesting These top-performing stocks have beaten the market in 2024 yet appear to have more room to run. 00:00 Introduction 00:43 Moderna MRNA 01:27 Hasbro HAS 02:06 Re...
2024 AMVCA: Saga, Ebuka, RMD, other red carpet stand-out looks (PHOTOS)
On the red carpet of the 10th AMVCA, which came to a grand close on Saturday night, the guys came battle-ready and gave the ladies a good run with their exquisite tastes and designs. The post 2024 AMV...
How Sage Capital is making money from other investors’ panic
Veteran hedge fund manager Sean Fenton has no qualms going against the crowd, buying ResMed after its collapse in 2023.
Decoding ResMed Inc (RMD): A Strategic SWOT Insight
Decoding ResMed Inc (RMD): A Strategic SWOT Insight
:max_bytes(150000):strip_icc():format(jpeg)/latestGainersLosers-da3dc30744c44554b28966c4ea038d8e.png)
S&P 500 Gains and Losses Today: Resmed Soars Amid Strong Demand for Sleep Devices
The S&P 500 jumped 1.0% on Friday, April 26, shaking off hot inflation data and receiving a boost from big tech earnings strength.
ResMed Inc's Meteoric Rise: Unpacking the 12% Surge in Just 3 Months
ResMed Inc's Meteoric Rise: Unpacking the 12% Surge in Just 3 Months
Why ResMed Stock Is Soaring Today
Investors liked the healthcare technology company's latest quarterly update.
ResMed Soars To Eight-Month High As Quarterly Report Wipes Out Weight-Loss Woes
ResMed stock jumped Friday after crushing sales estimates and wiping out worries that weight-loss drugs would squeeze sleep apnea device sales.
ResMed Analysts Boost Their Forecasts After Better-Than-Expected Earnings
ResMed (NYSE: RMD) reported better-than-expected third-quarter financial results on Thursday. ResMed posted adjusted earnings of $2.13 per share, beating market expectations of $1.91 per share. The c...
ResMed Stock Soars After Strong Earnings. Wall Street Thinks It Can Do Even Better.
The medical devices company beat expectations for its fiscal third quarter.
ResMed Inc. 2024 Q3 - Results - Earnings Call Presentation
The following slide deck was published by ResMed Inc.
ResMed Inc. (RMD) Q3 2024 Earnings Call Transcript
ResMed tops quarterly profit estimates on strong demand for sleep apnea devices
ResMed beat Wall Street estimates for quarterly profit on Wednesday due to strong demand for its sleep apnea devices, sending shares 9% higher in extended trading.
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024
Note: A webcast of ResMed's conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com
ResMed Unusual Options Activity
Benzinga's options scanner just detected over 10 options trades for ResMed (NYSE: RMD) summing a total amount of $532,171. At the same time, our algo caught 3 for a total amount of 179,581. Predicted...
How The Weight-Loss Bonanza Prompted A ResMed Sell-Off — But Could Soon Drive Shares Higher
ResMed stock jumped Thursday after an analyst suggested the growing popularity of weight-loss drugs could drive use of its medical devices.
Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank
The company published some very good news from the lab, although it wasn't so encouraging for smaller rivals.
ResMed Unusual Options Activity For April 17
Whales with a lot of money to spend have taken a noticeably bullish stance on ResMed . Looking at options history for ResMed (NYSE: RMD) we detected 10 trades. If we consider the specifics of each tr...
Eli Lilly Pops After Weight-Loss Drug Succeeds In Sleep Apnea Test; ResMed Dives
Eli Lilly stock popped Wednesday — and pushed ResMed stock lower — after its weight-loss drug reduced sleep apnea symptoms.
ASX stocks at risk from Ozempic – and ResMed isn’t one of them
Morgan Stanley brokers say the explosion of interest in the weight loss drugs will be far bigger than first thought. And these major companies could get hit.
Needham sees BSX, CNMD, RMD beating Street, despite medtech slow down
Needham estimates Q1 medtech sales grew less than expected, but that Boston Scientific, CONMED, ResMed and Surmodics should still be able to beat the Street. Read more here.
Mizuho sees ResMed as "overwhelming beneficiary" of Philips consent decree
ResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024
SAN DIEGO, April 04, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2024 on Thursday, ...
316 pensioners on Wexfords housing list including two people over the age of 90
While the housing crisis is forcing many of Wexfords younger generation to emigrate in search of a better life, it is also impacting the countys older populace. At the March meeting of the Rosslare Mu...